Gibson Dunn Advises XOMA Royalty Corporation on Acquisition of HilleVax, Inc.
Dan Mulloy
Gibson Dunn is representing XOMA Royalty Corporation, a publicly traded biotech royalty aggregator, on its acquisition of HilleVax, Inc. (Nasdaq: … The post Gibson Dunn Advises XOMA Royalty Corporation on Acquisition of HilleVax, Inc. appeared first on Gibson Dunn .